Pfizer Limited (PFIZER)
Healthcare | Drug Manufacturers - General
₹4792.5
-3.07% (₹152.0)
Market Overview
| Market Cap | 219245854720 |
| Volume | 19094 |
| 52W High | ₹6451.15 |
| 52W Low | ₹3950.0 |
Key Ratios
| P/E Ratio | 35.50526 |
| EPS | 134.98 |
| Beta | 0.236 |
| Dividend Yield | 0.0070999996% |
Financial Performance
Revenue Growth
0.023%
Profit Margin
0.27609%
ROE
0.17593999%
ROA
0.096260004%
Stock Analysis Score: 60/100
Growth Score: 60/100
Key Strengths:
- Excellent profit margins above 15%
- Strong ROE above 15%
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Buy - The stock shows good fundamentals with some room for improvement
Detailed Analysis
Growth: 0.0% revenue growth indicates weak business expansion.
Profitability: 27.6% profit margin shows excellent operational efficiency.
Returns: ROE of 17.6% demonstrates strong return on shareholder investment.
Valuation: PE ratio of 35.5x is expensive compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹21924.6Cr
- Beta: 0.24 (Market Volatility)
- 52-Week Range: ₹3950.0 - ₹6451.1
Last Updated: 2025-01-23 06:51:35